DIPNA PHARMACHEM LIMITED Share Price

DIPNA PHARMACHEM LIMITED Share Price

BSE: 543594
|
Trading
|
S Cap
₹ 4.61
-₹0.22 (-4.55%)
1D
Last updated 23 Sep, 2026, 15:25 IST

DIPNA PHARMACHEM LIMITED Share Price Today

As of 24 Sep 2026, DIPNA PHARMACHEM LIMITED share price is ₹4.61. The stock opened at ₹5.03, compared to its previous close of ₹4.83. During today's trading session, DIPNA PHARMACHEM LIMITED share price moved in the range of ₹4.61 to ₹5.03, with an average price of ₹4.82 for the day. Looking at its last 52-week, the stock has touched a low of ₹3.90 and a high of ₹25.00.

₹4.61
4.55% down today
₹5.03
1D LOW
1D HIGH

DIPNA PHARMACHEM LIMITED Returns Calculator

Circuit
L
H
₹4.59
₹5.07
52-week
L
H
₹3.90
₹25.00

About DIPNA PHARMACHEM LIMITED

DIPNA PHARMACHEM LIMITED Share Price
ISIN
INE0MC401013
Sector Market Cap
₹ 17.09 Cr

Dipna Pharmachem Limited is an India-based trader, importer, and exporter in industrial chemical and pharmaceutical raw materials, active pharmaceutical ingredients (APIs), solvents, and formulation. The Company is primarily engaged in a single segment, which is pharmaceutical trading. Its products include aceclofenac, acetazolamide, albendazole, ambroxol hcl, amisulpride ip/bp, amoxicillin aripiprazole ip, azithromycin, cefixime, carbamezapin, calcium gluconate ip, cefadroxyl monohydrate ip/bp/ep cephalexin, clindamycin phosphate ip/bp/usp, clotrimazole, cetrimide powder, chlorhexidine base, chlorhexidine hydrochloride, Bronopol, cm-1000, calcium cmc, calcium carbonate (light), calcium carbonate (oys), ceto stearyl alcohol, citric acid (anhydrous), and citric acid (monohydrate). It also provides assistance in setting up contract manufacturing compliance for regulated and semi-regulated pharmaceutical companies with all the global benchmark parameters of certificates like WHO-GMP.

DIPNA PHARMACHEM LIMITED Financial Highlights

  • Revenue: DIPNA PHARMACHEM LIMITED reported revenue of ₹129.11 crore in FY26 vs ₹124.93 crore in FY25. It showed an increase of 3.35% on a yearly basis.
  • Operating Profit: DIPNA PHARMACHEM LIMITED reported an operating profit of ₹3.54 crore in FY26 vs ₹1.42 crore in FY25. It showed an increase of 149.30% on a year-on-year basis.
  • Net Profit: DIPNA PHARMACHEM LIMITED reported a net profit of ₹2.63 crore in FY26 vs ₹0.97 crore in FY25. It showed an increase of 171.13% on a yearly basis.

DIPNA PHARMACHEM LIMITED Quarterly Result Highlights

  • DIPNA PHARMACHEM LIMITED reported revenue of ₹2.05 crore in Mar 2026, compared with ₹53.52 crore in Dec 2025, representing a decrease of 96.17% on a quarter-on-quarter (QoQ) basis.
  • DIPNA PHARMACHEM LIMITED reported an operating profit of ₹0.22 crore in Mar 2026, compared with ₹1.42 crore in Dec 2025, representing a decrease of 84.51% on a quarter-on-quarter (QoQ) basis.
  • DIPNA PHARMACHEM LIMITED reported a profit of ₹0.18 crore in Mar 2026, compared with ₹1.04 crore in Dec 2025, reflecting a decrease of 82.69% on a QoQ basis.
  • The earnings per share (EPS) of DIPNA PHARMACHEM LIMITED stood at ₹0.41 during Mar 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
9.13%
FII
0.00%
Other DII
0.00%
Retail and other
90.87%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Nov 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
17.09
P/E
17.57
P/B
0.41
ROE
3.48%
D/E
0.23
ROCE
6.70%
Div. Yield
0.00%
EPS(TTM)
1.00
Turnover
1.78
EV/EBITDA
6.06
Net Margin
0.00%
Op. Margin
0.00%
ROA
0.90%
Quick Ratio
0.00
Curr. Ratio
1.69
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Dipna Pharmachem has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Dipna Pharmachem appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

DIPNA PHARMACHEM LIMITED Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹124.92₹164.34₹99.93₹72.76
Other Income₹0.01₹0.00₹0.01₹0.01
Total Revenue₹124.93₹164.34₹99.93₹72.77
Total Expenses₹123.51₹162.92₹98.55₹71.19
Profit Before Tax₹1.42₹1.42₹1.38₹1.57
Tax₹0.45₹0.33₹0.47₹0.41
Profit After Tax₹0.97₹1.09₹0.91₹1.17
EPS - Basic₹0.41₹0.45₹0.76₹333.39
EPS - Diluted₹0.41₹0.45₹0.76₹333.39

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹1.42₹1.42₹1.38₹1.57
Income before WC changes₹3.45₹3.43₹2.35₹2.19
Change in Assets-₹12.92-₹47.16-₹35.85-₹11.48
Change in Liabilities₹0.72₹38.65₹12.99₹12.51
Change in WC-₹12.20-₹8.51-₹22.86₹1.03
Cash flow from Operations-₹9.19-₹5.42-₹20.98₹2.81
Cash flow from Investing-₹0.02-₹0.01-₹0.01-₹0.01
Cash flow from Financing-₹4.24₹13.62₹26.47-₹2.84
Total Cash Flow-₹13.45₹8.19₹5.48-₹0.04
Cash (Start of the year)₹13.88₹5.69₹0.21₹0.25
Cash (End of the year)₹0.43₹13.88₹5.69₹0.21

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹0.05₹0.04₹0.04₹0.04
Current Assets₹132.33₹132.87₹77.52₹36.19
Total Assets₹132.38₹132.91₹77.56₹36.23
Current Liabilities₹85.00₹82.84₹42.23₹28.69
Net Current Asset₹47.33₹50.03₹35.29₹7.50
Non-Current Liabilities₹8.89₹12.55₹10.97₹5.80
Equity Capital₹38.49₹37.52₹24.36₹1.74
Total Equity & Liabilities₹132.38₹132.91₹77.56₹36.23
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
1
Neutral
5
Bullish
2
Slightly Bullish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
41.96
Neutral
ATR (14)
0.26
Neutral
STOCH(9,6)
40
Neutral
STOCH RSI (14)
26.25
Neutral
ADX(9)
16.12
Bullish
UO(9)
39.54
Neutral
ROC(12)
-20.52
Bearish
WillR(14)
-82.5
Bullish
Period
Simple value
Exponential vaue
5D
4.61
4.66
10D
4.67
4.76
20D
5.05
4.97
50D
5.14
5.42
100D
6.26
6.47
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
DIPNA PHARMACHEM LIMITED Share Price
DIPNA PHARMACHEM LIMITED
Trading
Add Stock
Add Another

DIPNA PHARMACHEM LIMITED Share Price FAQs

DIPNA PHARMACHEM LIMITED share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837